Table 4—

Prevalence of microvascular and macrovascular events in patients with and without MH

MH group (n = 97)MN group (n = 73)Odds ratio (95% CI)
Medical events
 Nephropathy430417.9 (25.0–7,000)*
  Microalbuminuria320184.2 (11.0–3,060)*
  Clinical albuminuria10034.2 (2.0–578)*
 Retinopathy1892.0 (1.0–4.3)*
  Nonproliferative1351.9 (0.7–5.2)
  Preproliferative14019.5 (1.1–338)*
  Proliferative1381.7 (0.6–4.8)
 CHD42102.0 (0.8–5.0)*
 CVD60104.1 (1.6–10.6)*
Medical treatment
 Therapy for hypertension
  Oral drugs35124.3 (2.2–8.3)*
 Therapy for diabetes
  Oral drugs/or insulin53372.0 (0.7–5.7)
  • Data are %. The numbers are percent ratios of the events occurred in patients of each group obtained from all subjects and of patients treated with drugs for hypertension or diabetes obtained from all subjects.

  • *

    * P < 0.01 versus patients with MH.